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Medical malpractice in the endovascular era: Has
the standard of care changed?
O. William Brown, MD, JD, Detroit, East Lansing, and Royal Oak, MichThe most commonly accepted definition of standard of
care is “what an ordinary (reasonable) physician would do
in like or similar circumstances.” However, the advent of
the endovascular era and rapid advances in endovascular
technology has resulted in a re-examination of what consti-
tutes the standard of care for the treatment of several
vascular disease entities, including lower extremity arterial
occlusive disease, carotid disease, aortic aneurysmal disease,
and venous disease. The vascular community must now ask
itself: Are there instances in which endovascular techniques
have replaced those of open surgery as the standard of care?
If so, how are vascular specialists to recognize when these
changes have occurred?
Determining if the standard of care has changed is an
essential component of every medical malpractice lawsuit.
The plaintiff’s attorney has the responsibility to establish
the standard of care and prove that the defendant physician
violated that standard. Standard of care may be determined
in one of several ways:
1. The defendant in a medical malpractice case admits that
he or she breached the standard of care in the treatment
of the patient.
2. A plaintiff who is a medical expert may establish the
standard of care.
3. Res ipsa loquitor; which simply translated means, “it
speaks for itself.” The classic example of res ipsa loquitor
is leaving a sponge in the abdomen after a surgical
procedure.
4. If even a layperson would know that the standard of care
has been violated, no expect testimony is necessary. An
example of this would be performing multiple radio-
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800graphs on a pregnant woman in the first trimester of the
pregnancy.
5. The use of a medical expert witness, which is the most
common. As an example of the fifth method, one vas-
cular surgeon testifies that the standard of care in the
treatment of a patient with significant carotid artery
stenosis is angioplasty and stenting, whereas a second
vascular surgeon testifies that carotid endarterectomy is
the standard of care for the treatment of such patients. It
would then be up to the jury to decide which witness
was telling the truth. Unfortunately, this can be quite
difficult for the lay individual who is unaccustomed to
critically evaluating medical data.
Although at first glance it appears easy to simply blame
unethical medical experts for this dilemma, the problem
goes much deeper. In the past, the standard of care was
determined by the location in which the physician prac-
ticed; that is, by the locality rule. Physicians who practiced
in a rural area or in a small hospital were not held to the
same standard as physicians who practiced in an academic
center or a large metropolitan hospital. However, with the
standardization of medical school and residency training
programs, the standard of care has become a national
standard.
Unlike with public laws, the treatment of a specific
disease entity does not vary from state to state. In Hall v
Hilbun (466 So.2d 856), Dr Hoerr, a general surgeon
from Cleveland, Ohio, was not allowed to provide testi-
mony regarding the standard of care for a general surgical
patient in Pascagoula, Mississippi. The defendant, Dr
Hilbun, consequently prevailed. On appeal, however, the
appellate court reversed the trial court’s decision. The court
stated:
Once he has become informed of the facilities, etc. avail-
able to the defendant physician, the qualified medical
expert may express an opinion what the care duty of the
defendant physician was and whether the acts or omis-
sions of the defendant physician were in with or fell
substantially short of compliance with, that duty.
As stated above, the locality rule does, however, remain
in effect when considering equipment, services, and facili-
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Although it is unreasonable to assume that a 128-slice
computed tomography scanner should be available to every
vascular surgeon in practice, it is reasonable to require that
every vascular surgeon have access to some type of basic
x-ray imaging equipment.
The evolution of new scientific studies coupled with
rapid advances in medical technology naturally alters the
customary practice of physicians. This constant modifica-
tion in the customary practice of medicine can lead to a
significant conflict for physicians who believe that the
present standard of care is dangerous, but a new standard of
care has not yet been generally accepted. In most cases, the
legal system has been unwilling to permit evidence that
attacks the present standard of care unless a new standard
has been established. There are notable exceptions, how-
ever.
In Burton v Brooklyn Doctors Hospital (88 A.D.2d 217,
452 N.Y.S.2d 875 [1982]), the plaintiff was a premature
newborn who had been exposed to extended periods of
oxygen. At the time, it was generally held that the use of
large doses of oxygen decreased the incidence of brain
damage and death in premature infants. However, there
also existed a significant segment of themedical community
that believed the increased use of oxygen contributed to the
development of retrolental fibroplasia. The trial court
found that the defendant physician violated the standard of
care by not discontinuing the oxygen, even though many
textbooks still recommended the use of large doses of
oxygen in premature infants. On appeal, the appellate court
stated:
. . . [T]he jury’s finding of malpractice should not be
disturbed. The issue was submitted to the jury under
proper charge. If a physician fails to employ his expertise
or best judgment, and that omission causes injury, he
should not automatically be freed from liability because in
fact he adhered to acceptable practice.
InToth v Community Hospital at Glen Cove (22N.Y.2d
255, 292 N.Y.S.2d 440), the court stated:
. . . evidence that the defendant followed customary
practice in not the sole test of professional malpractice.
There is no policy reason why a physician, who knows or
believes there are unnecessary dangers in the community
practice, should not be required to take whatever precau-
tionary measures he deems appropriate.
Finally, in Nowatske v Osterloh (198 Wis.2d 419,
543N.W.2d 265, 272 [1996]), the Wisconsin Supreme
Court stated:
. . . [S]hould customary medical practice fail to keep pace
with developments and advances in medical science, ad-
herence to custom might constitute a failure to exercise
ordinary care . . . while evidence of the usual and custom-
ary conduct of others under similar circumstances is ordi-
narily relevant and admissible as an indication of what is
reasonably prudent, customary conduct is not dispositiveand cannot overcome the requirement that physicians
exercise ordinary care.
If the standard of care is constantly undergoing revi-
sion, we must determine what type of scientific evidence
may be admitted to establish that a new standard care exists
for the treatment of a given disease entity. One test that the
court presently recognizes for determining the admissibility
of evidence regarding new medical data is the Daubert test.
In Daubert v Merrill Dow Pharmaceuticals, Inc (509 U.S.
579, 113 S.Ct. 2786, 125 L.Ed.2d. 469 [1993]), the court
stated that, in part, this test requires that testimony regard-
ing a new standard of care must be based upon “scientifi-
cally valid principles.” The new approach need not be
generally accepted as reliable in the medical community.
In an effort to codify the standard of care for different
diseases, several specialty societies have developed practice
guidelines or clinical pathways. These guidelines usually
represent a general consensus of a given group of specialists
regarding the treatment of a specific medical problem, and
in truth, should be viewed as an authoritative expert opin-
ion or a review article. It must be stressed that clinical
guidelines may vary from one part of the country to an-
other, and in fact, from one hospital to another, depending
on the facilities available.
In addition, practice guidelines established by a profes-
sional society, in an effort to avoid liability, are often
accompanied by disclaimers stating that such guidelines are
simply “suggestions” for treatment, and that ultimate treat-
ment must be tailored to the individual patient. Accord-
ingly, clinical guidelines do not constitute the “standard of
care,” and although adherence to such guidelines may
constitute some line of defense against a claim of medical
malpractice, it clearly does not provide immunity. Similarly,
a deviation from clinical guidelines is not synonymous with
a breach of the standard of care. Most importantly, clinical
guidelines must be corroborated by expert testimony and
may not be introduced by themselves as standard of care
evidence.
Clinical guidelines most often represent a compilation
of several articles and studies, and therefore, it seems rea-
sonable to rely on these compilations to establish a general
consensus on how the ordinary (reasonable) physician
should treat a given disease entity. However, in their exu-
berance to defend a particular approach to a medical prob-
lem, physicians will sometimes conclude that their isolated
cohort of patients proves that their own approach consti-
tutes the present “standard of care.”Most physicians would
agree that “one series does not a standard of care make.”
Statements published in a reputable medical journal pro-
claiming a new standard of care for a particular disease
entity may be all that a plaintiff’s attorney needs to prevail in
a medical malpractice case.
The standard of care for the management of the ische-
mic limb has been the focus of many articles recently
published in the vascular literature. The treatment of the
ischemic limb has undergone significant change in the
endovascular era. In the past, surgical intervention or sur-
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dality for arterial occlusive disease of the lower extremity.
Nevertheless, with the advent of new catheters and atherec-
tomy devices, as well as the increased use of thrombolytic
agents, has the “standard of care” for the treatment of
lower extremity ischemia changed?
In truth, the standard of care encompasses both endo-
vascular and open surgical treatment. However, a 2001
article published in the Journal of Interventional Cardiology
states that direct intra-arterial thrombolysis recently has
become the standard of care for acute limb ischemia sec-
ondary to thrombus, noting that this approach was more
beneficial than acute surgical intervention.1 Similarly, a
recent article published in the Journal of Vascular Surgery
announced that “common femoral endarterectomy should
remain the standard of care for occlusive disease of the
common femoral artery.”2 Does this mean that the use of
catheter thrombectomy for lower extremity clot or angio-
plasty with or without stenting for occlusive disease of the
common femoral artery is outside the standard of care?
Presently, great controversy remains over the treatment
of arterial occlusive disease of the superficial femoral and
popliteal arteries. A recent article in the Journal of Vascular
Surgery concluded that “angioplasty with selective stenting
is the preferred initial therapy over greater saphenous vein
bypass for TASC B lesions in patients with disabling inter-
mittent claudication who require intervention.”3 Is a vas-
cular surgeon who performs a femoropopliteal bypass in a
patient with this lesion guilty of malpractice? Most sur-
geons would answer that a surgeon who performs a femoral
popliteal bypass for an 8-cm superficial femoral artery oc-
clusion is not guilty of medical malpractice per se. Con-
sider, however, the 75-year-old man with a history of a
myocardial infarction who has a 2-cm noncalcified, isolated
left common iliac stenosis. In this era of endovascular
surgery, should the performance of an ileofemoral bypass or
a femorofemoral bypass be considered a breach of the
standard of care? I believe most vascular surgeons would
state that it would—or should—be considered a breach of
the standard of care. Clearly, the ordinary (reasonable)
vascular surgeon would perform an angioplasty and likely
place a stent when presented with similar circumstances.
The standard of care for the treatment of carotid artery
occlusive disease is also being closely scrutinized. A recent
article published in the Annals of Surgery concluded that
“carotid endarterectomy remains the standard of care even
in high risk patients.”4 In an article published in the Euro-
pean Journal of Vascular Surgery, however, the authors
concluded that “carotid artery stenting has become our
standard of care in preventing strokes. . . .”5 I believe that
these types of statements only benefit the legal community.
At this time, although any discussion of the treatment
alternatives for carotid artery occlusive disease must include
a discussion of carotid angioplasty and stenting, it is clear
that endarterectomy and angioplasty with stenting may be
considered within the standard of care, depending on the
patient’s presentation.Technologic advances have also altered the standard of
care for the treatment of aortic aneurysmal disease. A recent
article in the Journal of Vascular Surgery concludes that
“endovascular repair is safer and [and just as] effective
treatment [when] compared with open surgical repair for
abdominal aortic aneurysms.”6 However, many vascular
surgeons believe that in younger patients (aged 50 to 60
years), open surgical repair is a better treatment.
Although controversy obviously remains in select pa-
tient populations, consider again the 75-year-old patient
with a history of a myocardial infarction who presents with
a 6-cm abdominal aortic aneurysm and perfect anatomy for
any type of endograft. Is the performance of an open repair
in this patient a breach of the standard of care? Unless
extenuating circumstances exist, the ordinary (reasonable)
vascular surgeon, in like or similar circumstances, would
perform an endograft. It could again be argued that in the
endovascular era, in older patients with perfect anatomy for
an endovascular procedure, the standard of care for the
treatment of an abdominal aortic aneurysm would be the
placement of an endograft. It should be noted that al-
though a recent article in the Journal of Vascular Surgery
concluded, “In anatomically suitable patients, TAG treat-
ment of thoracic aneurysms is superior to surgical repair, at
5 years,”7 this represents a single cohort of patients and
should not constitute a change in the standard of care for
the treatment of thoracic aneurysms. Be assured, however,
that the plaintiff’s bar will use this article to allege that a
patient who underwent an open repair and developed para-
plegia would be out jogging if he or she had undergone an
endovascular repair and had not been subjected to the
“substandard” open repair.
The treatment of deep venous thrombosis (DVT) has
also undergone reevaluation in the endovascular era. In the
past, the standard of care for the treatment of DVT was
anticoagulation. A recent article published in Perspectives in
Vascular Surgery and Endovascular Therapy, however, con-
cluded that “endovascular removal of DVT is increasingly
becoming the standard of care. . . .”8 Again, although the
treatment of DVT is clearly undergoing evolution, it can-
not be said at this time that the ordinary (reasonable)
physician would choose to perform clot extraction for the
treatment of DVT. The physician might choose clot extrac-
tion, or might treat with anticoagulation alone.
As medical science and technology progress, a change
in the standard of care is inevitable. Leeches are no longer
the standard of care for the treatment of medical diseases.
Radical mastectomy is no longer the standard of care for
breast cancer. Sympathectomy is no longer the standard of
care for the treatment of arterial occlusive disease. It is often
difficult, however, to pinpoint at what specific time the
standard of care changes.
We need to remember that the standard of care is not
what the average physician would do, or what most physi-
cians would do, but what the ordinary (reasonable) physi-
cian would do in like or similar circumstances. It should
also be stressed that the ordinary (reasonable) physician
might choose one of several courses of action, therefore
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different modalities. As vascular surgeons, we must be
careful to remember this fact when asked to testify as an
expert witness in amedical malpractice trial. Simply because
a physician did not choose the course of action that you, as
the expert, might have chosen, does not mean that the
standard of care was violated. The treatment choices of an
individual surgeon do not constitute the standard of care.
Yet, we must be willing to acknowledge, as in the case
of the use of high-dose oxygen for the treatment of prema-
ture infants, when the accepted standard of care has been
replaced by a new standard. In this modern era of endovas-
cular surgery, many standards of care are presently being
re-evaluated. Although several endovascular procedures at
this time have become an alternative treatment modality for
the treatment of vascular disease and clearly fall within the
standard of care, it is time to recognize that in a few isolated
instances, the endovascular approachmay have replaced the
open approach as the standard of care.
As vascular surgeons, we remain the most qualified
individuals to best determine the standard of care for the
treatment of vascular disease because we are not biased by
an inability to perform either an open or endovascular
procedure. Accordingly, both the medical community and
the legal community will continue to look to vascularsurgery for guidance regarding the standard of care for the
treatment of vascular disease.
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